Royal London Asset Management Ltd. boosted its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 3.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 333,951 shares of the financial services provider's stock after buying an additional 12,026 shares during the quarter. Royal London Asset Management Ltd. owned approximately 0.06% of Aflac worth $37,336,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the company. Spinnaker Trust boosted its holdings in shares of Aflac by 2.7% during the third quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider's stock worth $405,000 after acquiring an additional 95 shares during the period. Secure Asset Management LLC boosted its holdings in shares of Aflac by 1.0% during the third quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider's stock worth $1,094,000 after acquiring an additional 96 shares during the period. Ascent Group LLC boosted its holdings in shares of Aflac by 0.6% during the second quarter. Ascent Group LLC now owns 17,231 shares of the financial services provider's stock worth $1,539,000 after acquiring an additional 99 shares during the period. Ieq Capital LLC boosted its holdings in shares of Aflac by 0.5% during the second quarter. Ieq Capital LLC now owns 21,775 shares of the financial services provider's stock worth $1,945,000 after acquiring an additional 101 shares during the period. Finally, New Century Financial Group LLC boosted its holdings in shares of Aflac by 2.5% during the third quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider's stock worth $469,000 after acquiring an additional 101 shares during the period. Institutional investors own 67.44% of the company's stock.
Wall Street Analyst Weigh In
AFL has been the subject of a number of research analyst reports. Evercore ISI reduced their price objective on Aflac from $104.00 to $102.00 and set an "underperform" rating for the company in a report on Wednesday. Bank of America boosted their price target on Aflac from $115.00 to $124.00 and gave the company a "buy" rating in a research note on Thursday, October 10th. UBS Group boosted their price target on Aflac from $84.00 to $109.00 and gave the company a "neutral" rating in a research note on Wednesday, August 14th. Piper Sandler boosted their price target on Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a research note on Wednesday, October 2nd. Finally, Truist Financial boosted their price target on Aflac from $100.00 to $105.00 and gave the company a "hold" rating in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $98.73.
Get Our Latest Stock Report on AFL
Aflac Price Performance
Shares of NYSE:AFL traded down $0.43 during trading on Friday, hitting $107.32. 1,913,390 shares of the company were exchanged, compared to its average volume of 2,211,922. The business's 50 day moving average is $111.11 and its 200-day moving average is $102.01. The company has a market capitalization of $59.62 billion, a P/E ratio of 16.16, a price-to-earnings-growth ratio of 2.04 and a beta of 0.97. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac Incorporated has a 1-year low of $75.07 and a 1-year high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to the consensus estimate of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The company's revenue for the quarter was down 40.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.84 earnings per share. Equities analysts forecast that Aflac Incorporated will post 7.27 earnings per share for the current year.
Aflac Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Wednesday, February 19th will be issued a dividend of $0.58 per share. The ex-dividend date is Wednesday, February 19th. This is an increase from Aflac's previous quarterly dividend of $0.50. This represents a $2.32 annualized dividend and a dividend yield of 2.16%. Aflac's dividend payout ratio is 30.12%.
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Further Reading
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.